BDNF and Parkinson disease: Several arguments support the use of astrocytes as a platform for producing dopamine and other molecules that may impact the development and treatment of PD, such as BDNF and GDNF, that can help preserve the few dopaminergic neurons remaining and improve the dopamine metabolism in the striatum [55, 56].